rank ligand
Søg
Fundne resultater: 1
Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ... « rank-ligand
(Hits: 173;hjemmeside tilføjet: Jun 14, 2015, rank-ligand)
Prolia® (denosumab), the first and only approved RANK Ligand inhibitor, has filed for approval worldwide for the treatment of postmenopausal osteoporosis.
